Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5320_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
84 Мб
Скачать
https://t.me/med1917
TABLE 20.1 (Continued)

Basis of
Classication Type of Tablets

(DR), for

coated
Mode of
administration
 
the release of the drug from the
  
 
the acidic gastric environment (e.g., peptides) or are irritating to the gastric mucosa (e.g., aspirin)
Effervescent • Effervescent tablets are designed
Description and Special
Advantages
• Enteric- coated tablets are coated

does not dissolve under acidic conditions.
 
 
dissolution.
for dispersion and/ or dissolution

• Effervescent tablets provide rapid drug dissolution into solution

absorption upon administration.
 
 
Drug Substance Requirements
and Other Considerations
 

mechanism such as gastric

of time.
 
enteric coating are cellulose acetate phthalate (CAP),
  
cellulose acetate trimellitate
®  
• Drug should be soluble or

• Drug should be absorbed through the stomach.
• Drug should be compatible

components of the dosage form.
Physicochemical Principle
of Formulation Example
• Enteric- coated tablets
 
targeted drug release
• Aspirin
• In addition to the drug
 
tablets contain an acidic and
 
component can be tartaric acid or succinic acid and the basic component is

bicarbonate. In the presence

react, liberating carbon

disintegrates the tablets, and produces effervescence.
 
effervescent buccal tablet (to reduce
 
in cancer patients)
 
tablet (for relief of


Pharmaceutical Dosage Forms and Drug Delivery
  
https://t.me/med1917
rate of drug dissolution, buccal absorption, and/ or smooth mouthfeel.
 

pediatric population.
Dispersible • Dispersible tablets are designed
for rapid dispersion in a spoonful

administration.
  
tablets designed for drug release
 
 
or other sharp taste.
 
or other sharp taste.
• Drug should not be bitter or have other sharp taste.
• Drug should be soluble.
 
 smooth tasting base such
as sorbitol or mannitol.
• Mannitol is sometimes

diluent, because it provides a cooling sensation due to its negative heat of solution

 

or coloring agents to improve

 
 
in the saliva.
 
disintegrating agents.
 

or coloring agents to improve

 
disintegrant.
 
ingredients and are designed ­ution from surface.
 

coloring agents to improve

 
tablets
 
• Cough drops
 
Tablets


https://t.me/med1917

20.2.2 Effervescent Tablets
Pharmaceutical Dosage Forms and Drug Delivery
            ­           
20.2.3 Chewable Tablets
    ­­   
20.2.4 Buccal and Sublingual Tablets
                  ­   
20.2.5 Lozenges
                   
20.2.6 Coated Tablets







 to personnel handling the tablets
https://t.me/med1917
Tablets
TABLE 20.2


Film Coating
Characteristics Sugarcoating
 

Coating material
composition
 

    

uncommon for prescrip­tion pharmaceuticals.

consumer products, such as candies.
Using organic Solvent(s) Water- Based



   
and colorant (e.g., iron


 
the use of organic solvents during the coating process.



      

  ().
        ­         
called lm- coated tablets.
                                     .
       
https://t.me/med1917
360
TABLE 20.3
Pharmaceutical Dosage Forms and Drug Delivery

Brand Names Manufacturer Active Ingredients Indications
   Asthma
  
transcriptase inhibitor
®
Sinemet
®

®

®- 24  Chlorpheniramine 

20.2.7 Enteric- Coated Tablets
®
  
 Salbutamol Bronchospasm, asthma
 Diclofenac sodium Osteoarthritis and rheumatoid
 Isradipine 

arthritis
           
     -
ventional immediate- release dosage forms.
 ®      
20.2.8 Immediate- Release Tablets
­ ­
20.2.9 Controlled Release Tablets
          ­  
https://t.me/med1917
Tablets
361
              ®) are 
                          ®­  ® 
.
20.3 Tablet Formulation
                           excipients  
 
       
            

formulations are listed in .
20.3.1 Diluents
     
diluents.
                            Figure 20.1). Mannitol has a negative heat of solution and, thus,
https://t.me/med1917
362
TABLE 20.4
Pharmaceutical Dosage Forms and Drug Delivery

Functional Role Examples Description and Functionality
Filler  
 
• Mannitol
• Sorbitol
Binder  
 
• Starch
Disintegrant • Croscarmellose sodium (CCS)
   
• Starch
    
 • Magnesium stearate
• Stearic acid
 
Coating material  

    
• glidant (e.g., talc)
 
Coloring agent  
 
  


 • Aspartame, saccharin sodium, sucralose, acesulfame
potassium
Flavoring agent   • Flavoring to overcome drug taste and/
   -
integration characteristics
 
granules for processing
• Disintegration of the tablet to granules
 
 

 
the surface of the compressed core tablets
 
 

 
 

of tablets
   
20.3.2 Adsorbents
            
https://t.me/med1917
Tablets
TABLE 20.5
363

A. Acetaminophen Tablets
Ingredient  
Acetaminophen  Drug
Sucrose 60 mg Filler
 q.s. Binder
Stearic acid 6 mg 
  
Corn starch 30 mg Disintegrant
Alginic acid 20 mg Disintegrant
B. Acetaminophen Tablets USP (Direct Compression)
 70.00  Drug
   Filler
 0.36  
100.00 
FIGURE 20.1         J. Pharm. Sci
20.3.3 Granulating Fluid
                                 ­
https://t.me/med1917
364
Pharmaceutical Dosage Forms and Drug Delivery
   ­  
­          
20.3.4 Binders
­       ­
          ­      
20.3.5 Glidants
               
20.3.6 Lubricants
                                                 
                
20.3.7 Disintegrants
­in vitro testing. Disintegrants help
https://t.me/med1917
Tablets

  
dissolution of the drug.
                            
into the center of the tablet.
      
binder, the latter is a superdisintegrant.
20.3.8 Miscellaneous
 
acesulfame potassium and saccharin sodium, are preferred because smaller quantities produce similar or

  N,N,NN
20.4 Manufacturing of Tablets
20.4.1 Requirements for Tableting
Figure 20.2    






20.4.2 Powder Flow and Compressibility
               